Skip to main content

News

By Dave Muoio | 04:00 pm | March 25, 2019
Also: Study uses VR to explore autism spectrum disorder brain activity; UPS eyeing in-home healthcare.
By Laura Lovett | 03:47 pm | March 25, 2019
The Eversense Bridge program is geared toward patients with high-deductible insurance plans or plans that don't cover the full cost of Eversense CGM, and allows them to purchase the system for $99. 
By Laura Lovett | 01:33 pm | March 25, 2019
Researchers found that 64 percent of mental health apps claimed efficacy, although only 14 percent included any evidence.
By Dave Muoio | 04:13 pm | March 22, 2019
Researchers noted transmissions of specific sensitive data, such as a user’s drug list, that could de-identify the user and be repurposed for commercial uses.
By Jack Kaufman | 01:22 pm | March 22, 2019
Whether by managing payments, connecting consumers to reimbursement options or just manufacturing cheap drugs themselves, these companies are taking aim at a problem that's building to a crisis.
By Dave Muoio | 04:37 pm | March 21, 2019
The free game evokes inflamed organs, tar-filled pits and other jarring imagery to drive home its metaphor for smoking's side effects.
By Laura Lovett | 03:36 pm | March 21, 2019
In a small study published in PLOS ONE, 80 percent of participants using a surrogate robot achieved clinically meaningful improvement on a modified version of the Action Research Arm Test. 
By Jonah Comstock | 03:36 pm | March 21, 2019
Partner AliveCor also got a mysterious new FDA clearance.
By Dave Muoio | 03:03 pm | March 21, 2019
Oregon Health & Science University's ongoing study has participants discussing memories and tapping their critical thinking skills multiple times each week.
By Dave Muoio | 12:25 pm | March 21, 2019
The company's software enables a more holistic approach to combatting the social determinants of health.